Cory berkland

The main apparatus (Fig. 1A), which provides fabrication of monodisperse microparticles, is based on passing a solution containing the sphere material, and any drug to be encapsulated, through a small nozzle or other orifice (20 μm to a few millimeters in diameter) to form a smooth, cylindrical jet.To controllably break the jet into droplets, the nozzle is vibrated by a piezoelectric ...

Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Na Zhang; Chuda Chittasupho; Chadarat Duangrat; Teruna J. Siahaan; Cory Berkland: 1-May-2017: Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells: Singkome Tima; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland; Siriporn OkonogiMark M Bailey 1 , Cory Berkland. Affiliation 1 Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, KS 66047, USA. PMID: 22816117 DOI: 10.4155/tde.10.15 Abstract Novel technologies to enhance therapeutic delivery and biomaterial performance are fundamental to the development of improved products with fewer unwanted ...Senior Research Scientist. (217) 244-6345. [email protected]. 2050 ECE Building. Teaching. ECE 110 - Introduction to Electronics.Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice Jun Yang1,2, Sheng-Xue Xie3, Yiling Huang1,4, Min Ling1, Jihong Liu2, Yali Ran1, Yanlin Wang4, J Brantley Thrasher1, Cory Berkland3, and Benyi Li*,1,4 1Department of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USAA polyelectrolyte complex for the controlled release of an oil and gas field chemical selected from the group consisting of (a) a gel-forming or cross-linking agent, (b) a scale inhibitor, (c) a corrosion inhibitor, (d) an inhibitor of asphaltene or wax deposition, (e) a hydrogen sulfide scavenger, (f) a hydrate inhibitor, (g) a breaking agent, and a surfactant.Cory Berkland. Solon E. Summerfield Distinguished Professor; Department of Pharmaceutical Chemistry; Contact Info. [email protected]. 785-864-1455. Cory Berkland. 2008, Macromolecules. Heterogeneity of oil reservoirs often leads to unproductive cycling of injected oil recovery chemicals, resulting in the loss of significant quantities of reserves. To maximize recovery efficiency, a blocking agent may be placed deep into high-permeability channels so that the subsequently injected chemicals ...

Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...Cory Berkland, The University of Kansas, Lawrence, Kansas, United States of America Akhilesh Bhambhani, Merck and Co Inc West Point, Doylestown, Pennsylvania, United States of America Michael Blaber, Florida State University, Tallahassee, Florida, United States of AmericaCory Berkland, Ph.D. Date. Friday, January 29, 2021 - 12:00pm. Location. University of Houston. Abstract. Basic principles have emerged for oral and intravenous drug design, but fewer efforts have aimed to create drugs that persist at the administration site or molecular structures thatAlhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory J et al. (2013) Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 4:741-57 Alhakamy, Nabil A; Berkland, Cory J (2013) Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Mol Pharm 10:1940-8Abdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA

1. Introduction. Leukemia is among the top 10 cancers diagnosed globally. It is a group of cancers of early blood-forming cells, which are characterized by the uncontrolled production and accumulation of blast or immature abnormal blood cells in the peripheral blood and bone marrow.Jian Qian a and Cory Berkland* ab Author affiliations * Corresponding authors a Department of Pharmaceutical Chemistry, The University of Kansas, Multidisciplinary Research Building, 2030 Becker Dr., Lawrence, KS 66047, USA E-mail: [email protected]. b Department of Chemical ...Visit the main Washington University in St. Louis website 1 Brookings Drive / St. Louis, MO 63130 / wustl.edu864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...

Cenezoic.

KU chemical and petroleum engineering associate professors Michael Detamore and Cory Berkland are collaborating on the project that could revolutionize the repair and treatment of degenerated cartilage. "Cartilage doesn't really heal well on its own," Detamore said. "It's not like bone where you put it in a cast, wait six weeks and ...Cory Berkland: Resources, Writing - review & editing. Michael J. Hageman: Writing - review & editing, Project administration, Supervision, Resources. Declaration of Competing Interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work …Sep 6, 2014 · The induction of immune response by presentation of antigen on or with immune stimulating “signal” is a primary design metric of vaccines. We rationalized that a similar strategy could also be used to design antigen-SITs to induce tolerance to autoantigen. Both approaches focus on the recognition, attack, and removal of a “foreign ... The company’s lead candidate, BBI-001, is an iron chelator for the treatment of hereditary hemochromatosis. Bond joins the St. Louis ecosystem after licensing technology originally developed at the University of Kansas. Bond was founded by St. Louisan and serial entrepreneur Cory Berkland, PhD.Dec 29, 2017 · J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.

J Pharm Innov (2010) 5:70-71 DOI 10.1007/s12247-010-9084- EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or persist in circulation due to exclusion from renal filtration ...Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Chad Groer 1 , Ti Zhang 1 , Ruolin Lu 2 , Shuang Cai 1 , Derek Mull 1 2 , Aric Huang 2 , Melanie Forrest 1 , Cory Berkland 2 3 , Daniel Aires 1 4 , Marcus Laird Forrest 1 2 Affiliations 1 HylaPharm LLC, 2029 Becker Dr, Lawrence, Kansas 66047, United States.Cory Berkland, Ph.D. Abstract Basic principles have emerged for oral and intravenous drug design, but fewer efforts have ... Berkland is a co-founder of Orbis Biosciences (purchased by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ: SVRA), Bond Biosciences, and Orion BioScience. Title: Microsoft Word - Cory Berkland Seminar Announcement ...Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with a variety of applications in medicine, including scaffolding for tissue engineering, dermatological fillers and viscosupplementation for osteoarthritis treatment. HA is available in most connective tissues in body fluids such as synovial fluid and the vitreous humor of …What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityHow it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ... El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752-1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731-2746.Nov 22, 2019 · Jian Qian 1 , Cory Berkland 2 Affiliations 1 Department of ... Electronic address: [email protected]. PMID: 31655253 PMCID: PMC6820273 DOI ... Our clinical studies will determine if BBI-001 can reduce or eliminate the need for lifelong phlebotomies in Hereditary Hemochromatosis patients,” said Dr. Cory Berkland, Bond’s CEO, Chairman ...Cory Berkland. Cory Berkland. Solon E. Summerfield Distinguished Professor. Department of Pharmaceutical Chemistry. Contact Info. [email protected].

Abstract. Antibiotic multi-resistant pneumonia is a risk associated with long term mechanical ventilation. Vancomycin is commonly prescribed for methicillin-resistant staphylococcus aureus infections; however, current formulations of vancomycin are only given intravenously. High doses of vancomycin have been associated with severe renal toxicity.

Our clinical studies will determine if BBI-001 can reduce or eliminate the need for lifelong phlebotomies in Hereditary Hemochromatosis patients," said Dr. Cory Berkland, Bond's CEO, Chairman ...TY - JOUR. T1 - Monodisperse liquid-filled biodegradable microcapsules. AU - Berkland, Cory. AU - Pollauf, Emily. AU - Varde, Neel. AU - Pack, Daniel W.Oct 11, 2021 · Cory J. Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, KS, 66045 USA. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, KS, 66047 USA. E-mail: [email protected] Search for more papers by this author Cory Berkland, Departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA. E-mail: [email protected] Read the full textCory Berkland, PhD, has been developing microencapsulation and drug delivery capabilities for more than a decade. Cory has a PhD in Chemical and Biomolecular Engineering from the University of Illinois, Urbana-Champaign, where he co-invented and developed the Orbis technology. Cory is a Professor of Pharmaceutical Chemistry and Chemical and ...1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer component of multiple approved products and exhibits versatility for drug delivery, since it is available in a wide range of molecular weights and offers multiple sites for chemical modification. 1–6 In the human body, HA is prevalent in cartilage, skin, and synovial fluid and is typically present as a very high molecular weight ...Singkome Tima, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland, Siriporn Okonogi. Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics 2017, 114, 57-68. DOI: …Patent number: 10398649. Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles. Type: Grant. Filed: October 16, 2017. Date of Patent: September 3, 2019. Assignee: Orbis Biosciences, Inc. Inventors: Cory Berkland, Milind Singh.Noncovalently associated cell-penetrating peptides for gene delivery applications. 2013 Jun;4 (6):741-57. doi: 10.4155/tde.13.44. Nabil A Alhakamy Adane S Nigatu Cory J Berkland Joshua D Ramsey. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA. 23738670. Kristin L. Aillon, Nashwa El-Gendy, Connor Dennis, Jeffrey P. Norenberg, Jacob McDonald and Cory Berkland . Iodinated NanoClusters as an Inhaled Computed Tomography Contrast Agent for Lung Visualization. Molecular Pharmaceutics 2010, 7 (4) , 1274-1282. DOI: 10.1021/mp1000718. Mark M. Bailey, Eric M. Gorman, Eric J. Munson and Cory Berkland . ...

Mike ler.

Aac indoor championships 2023.

Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityIntroduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ... 2.1. Determination of Cytotoxicity of Doxorubicin (Dox), Idarubicin (Ida), and Curcumin (Cur) on Leukemic Cell Viability by MTT Assay. A cell viability curve demonstrated Dox (Figure 1 A) and IDa (Figure 1 B) exhibited the highest cytotoxicity for EoL-1 cells, followed by U937, KG-1, and KG-1a cells.The cytotoxicity of all the treatments was assessed using an inhibitory concentration at a 50% ...Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells ...About KU Pharmaceutical Chemistry. The collaborative research environment within the Department of Pharmaceutical Chemistry, and with other departments at KU, exposes students to a wide array of modern research in the pharmaceutical sciences, invaluable for a successful career in the chosen field. Our large faculty with diversified interests ...Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar]Noncovalently associated cell-penetrating peptides for gene delivery applications. 2013 Jun;4 (6):741-57. doi: 10.4155/tde.13.44. Nabil A Alhakamy Adane S Nigatu Cory J Berkland Joshua D Ramsey. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA. 23738670. Brittany L. Hartwell, 1 Chad J. Pickens, 2 Martin Leon, 3 Laura Northrup, 2 Matthew Christopher, 2 J. Daniel Griffin, 1 Francisco Martinez-Becerra, 4 and Cory Berkland 1, 2, 5, * Brittany L. Hartwell 1 Bioengineering Graduate Program, University of Kansas 1520 West 15 th Street, Lawrence, KS 66045, USACory BERKLAND | Cited by 10,556 | of University of Kansas, Kansas (KU) | Read 249 publications | Contact Cory BERKLAND ….

Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Sep-2021: Correction to: Effect of fluoroscopic X-rays combined with iodinated radiographic contrast media on human hematological parameters (Toxicology and Environmental Health Sciences, (2021), 13, 3, (225-235), 10.1007/s13530-021-00093-7)Professor Berkland is currently CEO of Bond Biosciences and is an executive and chairman of the board for Kinimmune and Axioforce. The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health.Conflict of interest C. Berkland has a patent (US 20110287547 A1) on Ca-TAT peptides. These studies were not solicited or funded by any pharmaceutical company. ... Cory Berkland, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66045, USA.Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2021: Costunolide and parthenolide from Champi Sirindhorn (Magnolia sirindhorniae) inhibit leukemic cell proliferation in K562 and molt-4 cell linesSingkome Tima 1 , Siriporn Okonogi 2 , Chadarat Ampasavate 2 , Chad Pickens 3 , Cory Berkland 4 , Songyot Anuchapreeda 5 Affiliations 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand.Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorBarlas Büyüktimkin, 1 Qun Wang, 2 Paul Kiptoo, 1 John M. Stewart, 1 Cory Berkland, 1, 2 and Teruna J. Siahaan 1, * Barlas Büyüktimkin 1 Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSCory Berkland View For the in vitro release experiment, 50 µl of UM-3003 adsorbed alhydrogel formulation was mixed with 500 µl of adjuvant-free human plasma in a closed glass vial at 37 °C and ... Cory berkland, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]